Skip to content

ARC Medical

6 viewers · 30d

Total raised

$1.5M

6 filings since 2024 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $1.5M
ROUNDS
6
INVESTORS
8
FOUNDED
N/A
HQ
N/A
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
6

AI overview

Updated

ARC Medical Inc. is a clinical-stage therapeutics company dedicated to developing innovative solutions to prevent surgical adhesions, a prevalent complication following various surgical procedures. With a commitment to improving patient outcomes, the company focuses on clinical advancements that mitigate the risks associated with adhesive formations post-surgery.

What sets it apart

The company's proprietary liquid medical devices create temporary barrier films that significantly reduce the formation of surgical adhesions, thereby enhancing recovery and reducing post-operative complications.

Funding history

6 rounds
EquityOct 4, 2024
Form D/A
+$589K$1.5M total
EquityOct 4, 2024
Form D/A
+$825K$1.5M total
EquityOct 4, 2024
Form D/A
+$901K$1.5M total
EquityOct 4, 2024
Form D/A
+$1.0M$1.5M total
EquityOct 4, 2024
Form D/A
+$1.4M$1.5M total
EquityOct 4, 2024
Form D/A
+$1.5M$1.5M total

Products

1 tracked

IPCOAT™

Surgical Adhesion Prevention

IPCOAT™ is an innovative liquid medical device utilized during gynecological and abdominal surgeries. It flows across the surgical site to form a protective barrier film over tissues, proactively preventing the occurrence of adhesions that can emerge post-surgery.

  • Formulates a temporary adhesion barrier
  • Compatible with open and laparoscopic procedures
  • Designed for various surgical specialties